Showing 991-1000 of 1145 results for "".
- Oculus Names New Medical Directorhttps://modernod.com/news/oculus-names-new-medical-director/2478589/Oculus has announced that William Tullo, OD, FAAO, joined the company as a Medical Director on November 2nd, 2020. In this newly developed role, Dr. Tullo will provide clinical guidance and educate medical eye profess
- Alnylam Announces Progress with RNAi Therapeutics Platform, Including Oral Route of Administration and CNS and Ocular Deliveryhttps://modernod.com/news/alnylam-announces-progress-with-rnai-therapeutics-platform-including-oral-route-of-administration-and-cns-and-ocular-delivery/2476682/Alnylam Pharmaceuticals announced new advances in its RNAi therapeutics platform, including preclinical results demonstrating oral delivery of GalNAc-conjugated small interfering RNAs (siRNAs) – the molecules that mediate RNAi – directed to a liver target. Oral delivery could broaden the clinical
- AOA Announces 2019 National Optometry Hall of Fame Inducteeshttps://modernod.com/news/aoa-announces-2019-national-optometry-hall-of-fame-inductees/2476443/The American Optometric Association has announced the four ODs who will be inducted into the National Optometry Hall of Fame in 2019. This year’s inductees are: Murray Fingeret, OD; Donald Jarnagin, OD; Michael Mittelman, OD; and Glen Steele, OD.
- New England College of Optometry to Launch Hybrid OD Teaching and Training Programhttps://modernod.com/news/new-england-college-of-optometry-to-launch-hybrid-od-teaching-and-training-program/2480337/
- First-Hand Accounts From ODs Who Tested Positive With COVID-19https://modernod.com/news/first-hand-accounts-from-ods-who-tested-positive-with-covid-19/2477530/
- Study Probes ODs’ Attitudes About Blue-Light Blocking Deviceshttps://modernod.com/news/study-probes-ods-attitudes-about-blue-light-blocking-devices/2476599/A recent study found that optometrists remain split on the impact of blue light from electronic devices, such as computer and phone screens, and the effectiveness of blue light-blocking devices, according to reporting by Patrick Campbell in MD Magazine, as
- MediPrint Ophthalmics Unveils Phase 2b Trial Results for Drug-Eluting Contact Lens in Glaucoma Treatmenthttps://modernod.com/news/mediprint-ophthalmics-unveils-phase-2b-trial-results-for-drug-eluting-contact-lens-in-glaucoma-treatment/2482539/MediPrint Ophthalmics announced positive results from its phase 2b clinical trial of its 3D-printed, drug-eluting contact lens LL-BMT1. The results, presented by Ian Ben Gaddie, OD, FAAO, at the Ameri
- Prevent Blindness Announces Recipients of the 2024 Jenny Pomeroy Award and the Rising Visionary Awardhttps://modernod.com/news/prevent-blindness-announces-recipients-of-the-2024-jenny-pomeroy-award-and-the-rising-visionary-award/2482251/Prevent Blindness named Mission for Vision (MFV) the recipient of the 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health; and Erica Shelton, OD, MS, FAAO, Clinical Instructor and PhD Candidate, The Ohio State University College of Optometry, has been named as the r
- American Academy of Optometry Announces the 2023 Garlan W. Clay Award Recipientshttps://modernod.com/news/american-academy-of-optometry-announces-the-2023-garlan-w-clay-award-recipients/2481798/The American Academy of Optometry has announced the recipients of the 2023 Garland W. Clay award: From the College of Optometry, The Ohio State University, Columbus, Ohio: Donald O. Mutti, OD, PhD, FAAO Loraine T. Sinnott, PhD G. Lynn Mitchel
- Bryan Wolynski Named Chief Technology Officer at Lighthouse Guildhttps://modernod.com/news/bryan-wolynski-named-chief-technology-officer-at-lighthouse-guild/2480702/Bryan Wolynski, OD, FAAO, has been named Chief Technology Officer at Lighthouse Guild. Dr. Wolynski will oversee all technology resources for the organization, including the recently opened Lighthouse Guild Technology Center, and will develop strategies to bring the latest technological advances